A microRNA focus on acne
Acne (syn. acne vulgaris) is a common inflammatory skin disorder associated with puberty and adolescence. Driven by complex interactions between the pilosebaceous unit and Cutibacterium acnes (C. acnes) bacteria, the disease is characterised by comedonal lesions, papules, pustules and nodules that...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2024-02-01
|
| Series: | Dermatology Reports |
| Subjects: | |
| Online Access: | https://www.pagepress.org/journals/index.php/dr/article/view/9902 |
| _version_ | 1797331492104306688 |
|---|---|
| author | Sarah Gordon Alison M. Layton Sandra Fawcett Kehinde Ross |
| author_facet | Sarah Gordon Alison M. Layton Sandra Fawcett Kehinde Ross |
| author_sort | Sarah Gordon |
| collection | DOAJ |
| description |
Acne (syn. acne vulgaris) is a common inflammatory skin disorder associated with puberty and adolescence. Driven by complex interactions between the pilosebaceous unit and Cutibacterium acnes (C. acnes) bacteria, the disease is characterised by comedonal lesions, papules, pustules and nodules that appear predominantly on the face. Acne and sequelae such as scarring and pigment changes affect health-related quality of life negatively. Approvals for nucleic acid therapies (NATs) such as short-interfering RNA (siRNA) drugs and antisense oligonucleotides (ASOs) have surged in recent years, for rare disorders with little or no effective treatments. These advances, along with clinical trials for microRNA (miRNA) modulation in skin contexts, raise the possibility that NATs may have potential for future acne treatment regimens. In this review, we highlight potential miRNA targets for anti-acne therapy. We provide a brief overview of acne pathophysiology and highlight roles of C. acnes. We then focus on recently discovered differential effects of planktonic and biofilm C. acnes on a Toll-like receptor 2 (TLR2) axis spanning miR-146a-5p. We appraise miR-146a-5p in sebocytes before addressing the putative contributions of miR-21-5p, miR-233-3p and miR-150-5p to inflammatory axes in acne. We conclude with translational perspectives and considerations of patient involvement in miRNA-related research for acne.
|
| first_indexed | 2024-03-08T07:36:21Z |
| format | Article |
| id | doaj.art-8722cdb52e574dccb033dab0ab41794f |
| institution | Directory Open Access Journal |
| issn | 2036-7392 2036-7406 |
| language | English |
| last_indexed | 2024-03-08T07:36:21Z |
| publishDate | 2024-02-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | Dermatology Reports |
| spelling | doaj.art-8722cdb52e574dccb033dab0ab41794f2024-02-02T18:59:08ZengPAGEPress PublicationsDermatology Reports2036-73922036-74062024-02-0110.4081/dr.2024.9902A microRNA focus on acneSarah Gordon0Alison M. Layton1Sandra Fawcett2Kehinde Ross3School of Pharmacy, University of Birmingham, BirminghamSkin Research Centre, Hull York Medical School, University of York, York; Harrogate and District NHS Foundation Trust, HarrogateSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool; Institute for Health Research, Liverpool John Moores University, LiverpoolLiverpool John Moores University Acne (syn. acne vulgaris) is a common inflammatory skin disorder associated with puberty and adolescence. Driven by complex interactions between the pilosebaceous unit and Cutibacterium acnes (C. acnes) bacteria, the disease is characterised by comedonal lesions, papules, pustules and nodules that appear predominantly on the face. Acne and sequelae such as scarring and pigment changes affect health-related quality of life negatively. Approvals for nucleic acid therapies (NATs) such as short-interfering RNA (siRNA) drugs and antisense oligonucleotides (ASOs) have surged in recent years, for rare disorders with little or no effective treatments. These advances, along with clinical trials for microRNA (miRNA) modulation in skin contexts, raise the possibility that NATs may have potential for future acne treatment regimens. In this review, we highlight potential miRNA targets for anti-acne therapy. We provide a brief overview of acne pathophysiology and highlight roles of C. acnes. We then focus on recently discovered differential effects of planktonic and biofilm C. acnes on a Toll-like receptor 2 (TLR2) axis spanning miR-146a-5p. We appraise miR-146a-5p in sebocytes before addressing the putative contributions of miR-21-5p, miR-233-3p and miR-150-5p to inflammatory axes in acne. We conclude with translational perspectives and considerations of patient involvement in miRNA-related research for acne. https://www.pagepress.org/journals/index.php/dr/article/view/9902MicroRNAnucleic acid therapeuticsskinsebaceous glandkeratinocytes |
| spellingShingle | Sarah Gordon Alison M. Layton Sandra Fawcett Kehinde Ross A microRNA focus on acne Dermatology Reports MicroRNA nucleic acid therapeutics skin sebaceous gland keratinocytes |
| title | A microRNA focus on acne |
| title_full | A microRNA focus on acne |
| title_fullStr | A microRNA focus on acne |
| title_full_unstemmed | A microRNA focus on acne |
| title_short | A microRNA focus on acne |
| title_sort | microrna focus on acne |
| topic | MicroRNA nucleic acid therapeutics skin sebaceous gland keratinocytes |
| url | https://www.pagepress.org/journals/index.php/dr/article/view/9902 |
| work_keys_str_mv | AT sarahgordon amicrornafocusonacne AT alisonmlayton amicrornafocusonacne AT sandrafawcett amicrornafocusonacne AT kehindeross amicrornafocusonacne AT sarahgordon micrornafocusonacne AT alisonmlayton micrornafocusonacne AT sandrafawcett micrornafocusonacne AT kehindeross micrornafocusonacne |